JPMorgan Chase & Co’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.2M | Buy |
1,584,206
+518,623
| +49% | +$4.65M | ﹤0.01% | 1959 |
|
2025
Q1 | $7.99M | Buy |
1,065,583
+591,207
| +125% | +$4.43M | ﹤0.01% | 2348 |
|
2024
Q4 | $3.57M | Sell |
474,376
-102,753
| -18% | -$773K | ﹤0.01% | 3005 |
|
2024
Q3 | $4.39M | Sell |
577,129
-170,402
| -23% | -$1.3M | ﹤0.01% | 2717 |
|
2024
Q2 | $4.62M | Buy |
747,531
+478,455
| +178% | +$2.96M | ﹤0.01% | 2572 |
|
2024
Q1 | $1.37M | Sell |
269,076
-278,461
| -51% | -$1.41M | ﹤0.01% | 3377 |
|
2023
Q4 | $3.28M | Sell |
547,537
-60,978
| -10% | -$365K | ﹤0.01% | 2828 |
|
2023
Q3 | $4.31M | Sell |
608,515
-23,000
| -4% | -$163K | ﹤0.01% | 2514 |
|
2023
Q2 | $4.45M | Buy |
631,515
+31,698
| +5% | +$223K | ﹤0.01% | 2561 |
|
2023
Q1 | $5M | Sell |
599,817
-194,720
| -25% | -$1.62M | ﹤0.01% | 2438 |
|
2022
Q4 | $9.12M | Buy |
794,537
+20,334
| +3% | +$233K | ﹤0.01% | 1988 |
|
2022
Q3 | $9.76M | Buy |
774,203
+225,163
| +41% | +$2.84M | ﹤0.01% | 1876 |
|
2022
Q2 | $5.81M | Buy |
549,040
+348,759
| +174% | +$3.69M | ﹤0.01% | 2289 |
|
2022
Q1 | $3.26M | Buy |
200,281
+17,823
| +10% | +$290K | ﹤0.01% | 2854 |
|
2021
Q4 | $2.53M | Sell |
182,458
-3,625
| -2% | -$50.2K | ﹤0.01% | 3074 |
|
2021
Q3 | $2.67M | Sell |
186,083
-11,403
| -6% | -$164K | ﹤0.01% | 2987 |
|
2021
Q2 | $3.12M | Buy |
197,486
+33,518
| +20% | +$530K | ﹤0.01% | 2946 |
|
2021
Q1 | $1.67M | Sell |
163,968
-16,372
| -9% | -$167K | ﹤0.01% | 3348 |
|
2020
Q4 | $1.34M | Sell |
180,340
-7,784
| -4% | -$58K | ﹤0.01% | 3208 |
|
2020
Q3 | $722K | Sell |
188,124
-1,565
| -0.8% | -$6.01K | ﹤0.01% | 3231 |
|
2020
Q2 | $904K | Buy |
189,689
+33,154
| +21% | +$158K | ﹤0.01% | 3063 |
|
2020
Q1 | $313K | Sell |
156,535
-265,627
| -63% | -$531K | ﹤0.01% | 3524 |
|
2019
Q4 | $1.46M | Sell |
422,162
-377,812
| -47% | -$1.3M | ﹤0.01% | 2874 |
|
2019
Q3 | $2.29M | Buy |
799,974
+501,377
| +168% | +$1.44M | ﹤0.01% | 2658 |
|
2019
Q2 | $1.08M | Sell |
298,597
-19,532
| -6% | -$70.9K | ﹤0.01% | 3022 |
|
2019
Q1 | $2.59M | Sell |
318,129
-54,011
| -15% | -$440K | ﹤0.01% | 2509 |
|
2018
Q4 | $3M | Sell |
372,140
-11,421
| -3% | -$92.2K | ﹤0.01% | 2411 |
|
2018
Q3 | $2.93M | Buy |
383,561
+355,418
| +1,263% | +$2.71M | ﹤0.01% | 2571 |
|
2018
Q2 | $161K | Buy |
28,143
+8,416
| +43% | +$48.1K | ﹤0.01% | 3912 |
|
2018
Q1 | $94K | Sell |
19,727
-1,411
| -7% | -$6.72K | ﹤0.01% | 3946 |
|
2017
Q4 | $104K | Buy |
+21,138
| New | +$104K | ﹤0.01% | 3891 |
|
2017
Q3 | – | Sell |
-244,613
| Closed | -$1.36M | – | 4286 |
|
2017
Q2 | $1.36M | Sell |
244,613
-6,242
| -2% | -$34.7K | ﹤0.01% | 2775 |
|
2017
Q1 | $2.11M | Buy |
250,855
+237,466
| +1,774% | +$1.99M | ﹤0.01% | 2581 |
|
2016
Q4 | $85K | Buy |
+13,389
| New | +$85K | ﹤0.01% | 3917 |
|
2015
Q4 | – | Sell |
-53,901
| Closed | -$614K | – | 4068 |
|
2015
Q3 | $614K | Sell |
53,901
-227,799
| -81% | -$2.59M | ﹤0.01% | 2875 |
|
2015
Q2 | $4.21M | Buy |
+281,700
| New | +$4.21M | ﹤0.01% | 2175 |
|
2014
Q4 | – | Sell |
-36,520
| Closed | -$357K | – | 3389 |
|
2014
Q3 | $357K | Buy |
36,520
+10,898
| +43% | +$107K | ﹤0.01% | 3103 |
|
2014
Q2 | $326K | Buy |
25,622
+12,344
| +93% | +$157K | ﹤0.01% | 3172 |
|
2014
Q1 | $140K | Buy |
+13,278
| New | +$140K | ﹤0.01% | 3388 |
|
2013
Q3 | – | Sell |
-39,595
| Closed | -$61K | – | 3872 |
|
2013
Q2 | $61K | Buy |
+39,595
| New | +$61K | ﹤0.01% | 3756 |
|